ClinicalTrials.Veeva

Menu

Pilot Study to Determine Feasibility of Benign and Malignant Skin Lesion Detection.

O

Orlucent

Status

Completed

Conditions

Skin Lesions

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02009085
KH 2012

Details and patient eligibility

About

In this study a fluorescent contrast dye is applied to a suspicious skin lesion.

Images are acquired and processed. The information is used to develop a prediction model for the presence of malignant transformation in the skin.

Full description

Images acquired in the study are used for the development of a software analysis program.

Enrollment

126 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Over the age of 18
  • Individual is scheduled for a skin biopsy in toto
  • The lesion is pigmented or non pigmented
  • Lesions may be under suspicion for basal cell carcinoma, squamous cell carcinoma, actinic keratosis, nevi, melanoma, seborrheic keratosis.
  • The lesion is accessible to the imaging device

Exclusion criteria

  • The patient has sensitive skin and easily breaks out in rash
  • The lesion is within 1 cm of the eye
  • The lesion is on mucosal surfaces (e.g., lips, genitals)
  • Pregnant females
  • Taking medications that pigments the skin

Trial design

126 participants in 1 patient group

Individuals undergoing skin excision.
Description:
Skin lesions are under suspicion for skin cancer.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems